“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When ...

For most of his 20 years, a New Jersey man knew pain as a daily reality. Now, after a one-time CRISPR gene-editing treatment at Children's Hospital of Philadelphia, Austin Louis says he is finally ...

Lilly joins the growing list of big pharma companies hoping to see success from their acquired in vivo CAR-T programmes.

In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat ...

Glenn Polyak thought he was out of options when his Stage 4 melanoma spread to his brain, until he became only the second ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...

Immune cells in the brain that go rogue contribute to the death of neurons, so getting rid of them may slow the progression of neurodegenerative conditions like amyotrophic lateral sclerosis ...

A promising clinical trial underway at UCI Health is aimed at helping patients achieve long-term remission.

OU Health Stephenson Cancer Center told News 9 on Sunday that it is the only site in Oklahoma that offers a new cell therapy to treat advanced melanoma.

In 2024, tumor-infiltrating lymphocyte (TIL) therapy emerged. It’s the first and only FDA-approved treatment for metastatic melanoma tumors which are non-responsive to other treatments or cannot be ...